The global Phenotypic Drug Discovery market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The publisher report includes an overview of the development of the Phenotypic Drug Discovery industry chain, the market status of Cancer (Platform, Service), Viral Infection (Platform, Service), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Phenotypic Drug Discovery.
Regionally, the report analyzes the Phenotypic Drug Discovery markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Phenotypic Drug Discovery market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Phenotypic Drug Discovery market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Phenotypic Drug Discovery industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Platform, Service).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Phenotypic Drug Discovery market.
Regional Analysis: The report involves examining the Phenotypic Drug Discovery market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Phenotypic Drug Discovery market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Phenotypic Drug Discovery:
Company Analysis: Report covers individual Phenotypic Drug Discovery players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Phenotypic Drug Discovery This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer, Viral Infection).
Technology Analysis: Report covers specific technologies relevant to Phenotypic Drug Discovery. It assesses the current state, advancements, and potential future developments in Phenotypic Drug Discovery areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Phenotypic Drug Discovery market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Phenotypic Drug Discovery market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Platform
Service
Market segment by Application
Cancer
Viral Infection
Genetic Disease
Others
Market segment by players, this report covers
Eurofins Discovery
Sygnature Discovery
PsychoGenics
siTOOLs Biotech
PhoreMost
Charles River
MaxWell
Arctoris
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Phenotypic Drug Discovery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Phenotypic Drug Discovery, with revenue, gross margin and global market share of Phenotypic Drug Discovery from 2019 to 2024.
Chapter 3, the Phenotypic Drug Discovery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Phenotypic Drug Discovery market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Phenotypic Drug Discovery.
Chapter 13, to describe Phenotypic Drug Discovery research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Phenotypic Drug Discovery
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Phenotypic Drug Discovery by Type
1.3.1 Overview: Global Phenotypic Drug Discovery Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Phenotypic Drug Discovery Consumption Value Market Share by Type in 2023
1.3.3 Platform
1.3.4 Service
1.4 Global Phenotypic Drug Discovery Market by Application
1.4.1 Overview: Global Phenotypic Drug Discovery Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cancer
1.4.3 Viral Infection
1.4.4 Genetic Disease
1.4.5 Others
1.5 Global Phenotypic Drug Discovery Market Size & Forecast
1.6 Global Phenotypic Drug Discovery Market Size and Forecast by Region
1.6.1 Global Phenotypic Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Phenotypic Drug Discovery Market Size by Region, (2019-2030)
1.6.3 North America Phenotypic Drug Discovery Market Size and Prospect (2019-2030)
1.6.4 Europe Phenotypic Drug Discovery Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Phenotypic Drug Discovery Market Size and Prospect (2019-2030)
1.6.6 South America Phenotypic Drug Discovery Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Phenotypic Drug Discovery Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Eurofins Discovery
2.1.1 Eurofins Discovery Details
2.1.2 Eurofins Discovery Major Business
2.1.3 Eurofins Discovery Phenotypic Drug Discovery Product and Solutions
2.1.4 Eurofins Discovery Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Eurofins Discovery Recent Developments and Future Plans
2.2 Sygnature Discovery
2.2.1 Sygnature Discovery Details
2.2.2 Sygnature Discovery Major Business
2.2.3 Sygnature Discovery Phenotypic Drug Discovery Product and Solutions
2.2.4 Sygnature Discovery Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sygnature Discovery Recent Developments and Future Plans
2.3 PsychoGenics
2.3.1 PsychoGenics Details
2.3.2 PsychoGenics Major Business
2.3.3 PsychoGenics Phenotypic Drug Discovery Product and Solutions
2.3.4 PsychoGenics Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 PsychoGenics Recent Developments and Future Plans
2.4 siTOOLs Biotech
2.4.1 siTOOLs Biotech Details
2.4.2 siTOOLs Biotech Major Business
2.4.3 siTOOLs Biotech Phenotypic Drug Discovery Product and Solutions
2.4.4 siTOOLs Biotech Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 siTOOLs Biotech Recent Developments and Future Plans
2.5 PhoreMost
2.5.1 PhoreMost Details
2.5.2 PhoreMost Major Business
2.5.3 PhoreMost Phenotypic Drug Discovery Product and Solutions
2.5.4 PhoreMost Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 PhoreMost Recent Developments and Future Plans
2.6 Charles River
2.6.1 Charles River Details
2.6.2 Charles River Major Business
2.6.3 Charles River Phenotypic Drug Discovery Product and Solutions
2.6.4 Charles River Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Charles River Recent Developments and Future Plans
2.7 MaxWell
2.7.1 MaxWell Details
2.7.2 MaxWell Major Business
2.7.3 MaxWell Phenotypic Drug Discovery Product and Solutions
2.7.4 MaxWell Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 MaxWell Recent Developments and Future Plans
2.8 Arctoris
2.8.1 Arctoris Details
2.8.2 Arctoris Major Business
2.8.3 Arctoris Phenotypic Drug Discovery Product and Solutions
2.8.4 Arctoris Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Arctoris Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Phenotypic Drug Discovery Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Phenotypic Drug Discovery by Company Revenue
3.2.2 Top 3 Phenotypic Drug Discovery Players Market Share in 2023
3.2.3 Top 6 Phenotypic Drug Discovery Players Market Share in 2023
3.3 Phenotypic Drug Discovery Market: Overall Company Footprint Analysis
3.3.1 Phenotypic Drug Discovery Market: Region Footprint
3.3.2 Phenotypic Drug Discovery Market: Company Product Type Footprint
3.3.3 Phenotypic Drug Discovery Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Phenotypic Drug Discovery Consumption Value and Market Share by Type (2019-2024)
4.2 Global Phenotypic Drug Discovery Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Phenotypic Drug Discovery Consumption Value Market Share by Application (2019-2024)
5.2 Global Phenotypic Drug Discovery Market Forecast by Application (2025-2030)
6 North America
6.1 North America Phenotypic Drug Discovery Consumption Value by Type (2019-2030)
6.2 North America Phenotypic Drug Discovery Consumption Value by Application (2019-2030)
6.3 North America Phenotypic Drug Discovery Market Size by Country
6.3.1 North America Phenotypic Drug Discovery Consumption Value by Country (2019-2030)
6.3.2 United States Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
6.3.3 Canada Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
6.3.4 Mexico Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Phenotypic Drug Discovery Consumption Value by Type (2019-2030)
7.2 Europe Phenotypic Drug Discovery Consumption Value by Application (2019-2030)
7.3 Europe Phenotypic Drug Discovery Market Size by Country
7.3.1 Europe Phenotypic Drug Discovery Consumption Value by Country (2019-2030)
7.3.2 Germany Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
7.3.3 France Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
7.3.5 Russia Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
7.3.6 Italy Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Phenotypic Drug Discovery Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Phenotypic Drug Discovery Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Phenotypic Drug Discovery Market Size by Region
8.3.1 Asia-Pacific Phenotypic Drug Discovery Consumption Value by Region (2019-2030)
8.3.2 China Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
8.3.3 Japan Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
8.3.4 South Korea Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
8.3.5 India Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
8.3.7 Australia Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
9 South America
9.1 South America Phenotypic Drug Discovery Consumption Value by Type (2019-2030)
9.2 South America Phenotypic Drug Discovery Consumption Value by Application (2019-2030)
9.3 South America Phenotypic Drug Discovery Market Size by Country
9.3.1 South America Phenotypic Drug Discovery Consumption Value by Country (2019-2030)
9.3.2 Brazil Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
9.3.3 Argentina Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Phenotypic Drug Discovery Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Phenotypic Drug Discovery Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Phenotypic Drug Discovery Market Size by Country
10.3.1 Middle East & Africa Phenotypic Drug Discovery Consumption Value by Country (2019-2030)
10.3.2 Turkey Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
10.3.4 UAE Phenotypic Drug Discovery Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Phenotypic Drug Discovery Market Drivers
11.2 Phenotypic Drug Discovery Market Restraints
11.3 Phenotypic Drug Discovery Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Phenotypic Drug Discovery Industry Chain
12.2 Phenotypic Drug Discovery Upstream Analysis
12.3 Phenotypic Drug Discovery Midstream Analysis
12.4 Phenotypic Drug Discovery Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Eurofins Discovery
Sygnature Discovery
PsychoGenics
siTOOLs Biotech
PhoreMost
Charles River
MaxWell
Arctoris
听
听
*If Applicable.